268 related articles for article (PubMed ID: 88251)
1. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
[TBL] [Abstract][Full Text] [Related]
2. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
[TBL] [Abstract][Full Text] [Related]
4. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
7. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate in osteogenic sarcoma.
Jaffe N; Link MP; Cohen D; Traggis D; Frei E; Watts H; Beardsley GP; Abelson HT
Natl Cancer Inst Monogr; 1981 Apr; (56):201-6. PubMed ID: 6975438
[TBL] [Abstract][Full Text] [Related]
9. Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.
Rosen G; Caparros B; Groshen S; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Huvos AG
Cancer Invest; 1984; 2(3):181-92. PubMed ID: 6203625
[TBL] [Abstract][Full Text] [Related]
10. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.
Rosen G; Tefft M; Martinez A; Cham W; Murphy ML
Cancer; 1975 Mar; 35(3):622-30. PubMed ID: 1078640
[TBL] [Abstract][Full Text] [Related]
12. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Marroum MC; Huvos AG; Rosen G
Oncology; 1977; 34(6):273-80. PubMed ID: 304199
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
[TBL] [Abstract][Full Text] [Related]
14. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases.
Urban C; Rosen G; Huvos AG; Caparros B; Cacavio A; Nirenberg A
Cancer; 1983 Mar; 51(5):795-802. PubMed ID: 6295615
[TBL] [Abstract][Full Text] [Related]
18. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.
Rosen G; Marcove RC; Huvos AG; Caparros BI; Lane JM; Nirenberg A; Cacavio A; Groshen S
J Cancer Res Clin Oncol; 1983; 106 Suppl():55-67. PubMed ID: 6604058
[TBL] [Abstract][Full Text] [Related]
19. [Alternative chemotherapy of malignant bone neoplasms in children].
Jurczyk-Procyk S; Perek D
Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
[TBL] [Abstract][Full Text] [Related]
20. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
